Acute Coronary Syndromes Clinical Trial
Official title:
Personalized and Targeted Feedback in the ACTION-Registry-GWTG
This project is designed to examine the impact of tailored feedback on site performance.
The investigators' objective is to evaluate whether a 'personalized and targeted' feedback,
education and performance improvement intervention has a greater impact on adherence to
recommended guidelines than standard feedback.
The investigators hypothesize that a site-specific report with centrally identified targets
for improvement paired with target specific interventions will enable sites to quickly
identify and prioritize salient problem areas, have ready access to an analysis of factors
that underlie problems, and formulate an effective action plan. The investigators also
hypothesize that those hospitals randomized to receive intervention will be more likely to
improve their overall performance, as well as their target specific performance, during the
period of observation in direct response to activated QI processes.
Outcomes:
The primary outcome is improvement in the overall composite of all metrics eligible for
intervention regardless of their selection as targets.
The secondary outcome is improvement in the composite of targeted metrics.
Outcomes will be assessed in all participating sites, and in among relevant performance
subgroups (low performers, academic centers, full service, and among medication versus
process metrics).
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02552407 -
Thrombectomy in ST Elevation Myocardial Infarction, an Individual Patient Meta-analysis
|
N/A | |
| Completed |
NCT01398228 -
Clinical Pathways for the Management of Acute Coronary Syndromes - Phase 3,CPACS-3
|
N/A | |
| Completed |
NCT01135667 -
Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI
|
Phase 4 | |
| Recruiting |
NCT02592720 -
Cocktail Injection Improves Outcomes of FFR Guided PCI
|
Phase 4 | |
| Completed |
NCT01641510 -
PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic Variants
|
Phase 3 | |
| Completed |
NCT01743274 -
Does Optical Coherence Tomography Optimise Results of Stenting
|
N/A | |
| Active, not recruiting |
NCT01433627 -
Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX
|
Phase 3 | |
| Completed |
NCT01452282 -
Ankle-Brachial Index Estimating Cardiac Complications After Surgery
|
N/A | |
| Recruiting |
NCT01418794 -
Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease
|
Phase 4 | |
| Recruiting |
NCT01000701 -
Inflammation and Acute Coronary Syndromes
|
N/A | |
| Terminated |
NCT01107899 -
Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes
|
Phase 1 | |
| Completed |
NCT00494247 -
Endothelial Progenitor Cells-capture Stents in Acute Coronary Syndromes
|
Phase 4 | |
| Terminated |
NCT00615719 -
Computed Tomographic Coronary Angiography for Acute Chest Pain Evaluation
|
N/A | |
| Active, not recruiting |
NCT06089343 -
High-risk Features of Coronary Lesions in CTA and OCT
|
||
| Not yet recruiting |
NCT04023630 -
DUAL Antithrombotic Therapy in Patients With AF and ACS
|
Phase 4 | |
| Recruiting |
NCT02601404 -
REal World Advanced Experience of BioResorbable ScaffolD by SMart Angioplasty Research Team (SMART REWARD)
|
N/A | |
| Completed |
NCT02195193 -
Integrating Depression Care in Acute Coronary Syndromes Care in China
|
N/A | |
| Not yet recruiting |
NCT01735227 -
Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN)
|
Phase 4 | |
| Completed |
NCT02141750 -
THIRD NATIONAL REGISTRY OF ACUTE CORONARY SYNDROMES
|
N/A | |
| Completed |
NCT00097591 -
A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention
|
Phase 3 |